Journal of Medical Economics
Volume 24, 2021 - Issue 1
Open access
2,781
Views
0
CrossRef citations to date
0
Altmetric
Neurology
Societal costs of primary progressive multiple sclerosis in Australia and the economic impact of a hypothetical disease-modifying treatment that could delay disease progression
Laurie J. Browna National Centre for Social and Economic Modelling (NATSEM), Institute for Governance and Policy Analysis, University of Canberra, Canberra, ACT, AustraliaCorrespondence[email protected]
https://orcid.org/0000-0002-9357-5094
Jinjing Lia National Centre for Social and Economic Modelling (NATSEM), Institute for Governance and Policy Analysis, University of Canberra, Canberra, ACT, Australia
https://orcid.org/0000-0001-5640-2058
Matthias Brunnerb Roche Products Pty Limited, Sydney, NSW, Australia
, Martin Snokeb Roche Products Pty Limited, Sydney, NSW, Australia
& Hai A. Laa National Centre for Social and Economic Modelling (NATSEM), Institute for Governance and Policy Analysis, University of Canberra, Canberra, ACT, Australia
https://orcid.org/0000-0003-1063-3891
Pages 140-149
|
Received 15 Oct 2020, Accepted 14 Dec 2020, Published online: 29 Jan 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.